Category: FDA

6/30/2015

Harvard’s Jerry Avorn warns against FDA loosening off-label marketing restrictions

4 6/19/2015

Coverage of FDA’s trans fat decision a high-water mark for health journalism

2 6/10/2015

LDL – Lion King of Surrogate Endpoints – key cholesterol issue this week

10 6/5/2015

Astroturfers rule the day: FDA’s flibanserin reviewers were “emotionally blackmailed” by a slick lobbying campaign

3 6/3/2015

Pink Viagra may be coming soon (but for teetotalers, only!)

2 4/2/2015

Salon’s “female viagra is long overdue” piece fell into the disease mongering trap

3 3/25/2015

A call to ban advertising testosterone for anti-aging

2/12/2015

Academic science journalism project unveils gaps in reporting research misconduct

1 2/5/2015

Lots of reporting & CDC criticism in BMJ piece on antiviral drug Tamiflu

1/24/2014

JAMA papers raise questions about FDA drug and device approval